mpassarelli@engelog.ind.br

(11) 9.8755-4999

gw pharmaceuticals stock forecast

postado em

See what's happening in the market right now with MarketBeat's real-time news feed. GW Pharmaceuticals PLC has risen higher in 4 of those 7 years over the subsequent 52 week period, corresponding to a historical accuracy of 57.14 % According to 17 analysts, the average rating for GWPH stock is "Buy." GW Pharmaceuticals has a market capitalization of $6.85 billion and generates $311.33 million in revenue each year. View our earnings forecast for GW Pharmaceuticals. Fundamental company data provided by Zacks Investment Research. GW Pharmaceutical PLC GWPH, +0.11% shares rallied Monday after the cannabis-based medicine company forecast better-than-expected sales of its seizure treatment Epidiolex. Though shares of GW Pharmaceuticals are trading down almost 50% from their all-time high of $196 in 2019, with analyst predictions like these, this is a cannabis stock that investors should keep a close eye on in 2020. Company insiders that own GW Pharmaceuticals stock include Adam D George, Cabot Brown, Christopher J Tovey, Douglas B Snyder, Geoffrey W Dr Guy, James Noble, Julian S Gangolli, Justin D Gover, Scott M Giacobello, Volker Knappertz and William A Waldegrave. GWPH stock was sold by a variety of institutional investors in the last quarter, including Rothschild Investment Corp IL, Investors Financial Group LLC, Westside Investment Management Inc., and NEXT Financial Group Inc. Company insiders that have sold GW Pharmaceuticals company stock in the last year include Adam D George, Cabot Brown, Christopher J Tovey, Douglas B Snyder, Geoffrey W Dr Guy, Justin D Gover, and Volker Knappertz. View analyst ratings for GW Pharmaceuticals or view top-rated stocks. All rights reserved. GW Pharmaceuticals plc (NASDAQ:GWPH) posted its quarterly earnings data on Tuesday, February, 16th. The official website for GW Pharmaceuticals is www.gwpharm.com. Gw Pharmaceuticals's share price could stay at $192.40 by Feb 4, 2022. What is GWPH's earnings growth forecast for 2021-2023? Their forecasts range from $140.00 to $275.00. GW Pharmaceuticals has a P/B Ratio of 9.30. The stock dropped about 39% in the past twelve months, all along experiencing a high level of volatility. Stock Price Forecast The 10 analysts offering 12-month price forecasts for GW Pharmaceuticals PLC have a median target of 220.00, with a high estimate of 220.00 and a low estimate of 125.00. 326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257 We cover the US equity market. Wall Street analysts have given GW Pharmaceuticals a "Hold" rating, but there may be better short-term opportunities in the market. Find the latest GW Pharmaceuticals Plc (GWPH) stock quote, history, news and other vital information to help you with your stock trading and investing. On average, they anticipate GW Pharmaceuticals' share price to reach $204.09 in the next year. On average, Wall Street analysts predict that. GW Pharmaceuticals plc is a biopharmaceutical company focused on developing and commercializing therapeutics from its cannabinoid product platform in a range of disease areas. (Add your “underperform” vote.). GWPH stock was purchased by a variety of institutional investors in the last quarter, including Syquant Capital Sas, Havens Advisors LLC, Gofen & Glossberg LLC IL, International Assets Investment Management LLC, and Paragon Wealth Strategies LLC. The biopharmaceutical company earned $148.22 million during the quarter, compared to the consensus estimate of $145.46 million. GW Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Monday, May 10th 2021. So take a peek at this free list of interesting companies with past earnings growth (and further growth forecast). Get short term trading ideas from the MarketBeat Idea Engine. Its lead product is Epidiolex, an oral medicine for the treatment of seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, or tuberous sclerosis complex. … Get daily stock ideas top-performing Wall Street analysts. Gw Pharmaceuticals (NASDAQ: GWPH) is owned by 6.57% institutional shareholders, 2.21% Gw Pharmaceuticals insiders, and 91.22% retail investors. GW Pharmaceuticals' stock is owned by a number of institutional and retail investors. Price Target. There are currently 10 hold ratings and 4 buy ratings for the stock. Our Accessibility Statement | Terms of Service | Do Not Sell My Information. GW Pharmaceuticals - ADR Stock Price Forecast, "GWPH" Predictons for2021 GW Pharmaceuticals does not have a long track record of dividend growth. View all of GWPH's competitors. Learn more. Is Gw Pharmaceuticals Stock a good buy in 2021, according to Wall Street analysts? What is GWPH's forecast return on assets (ROA) for 2021-2024? GW Pharmaceuticals had a negative trailing twelve-month return on equity of 7.46% and a negative net margin of 11.05%. GW Pharmaceuticals has received 59.60% “outperform” votes from our community. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. View GWPH's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. GW Pharma stock blogger sentiment is based on 9 bloggers opinions, the blogger sentiment for GWPH is more bullish than other stocks in the Healthcare sector. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. As of 2021 April 18, Sunday current … Shares of GWPH can be purchased through any online brokerage account. Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on US exchanges. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. That said, GW Pharmaceuticals is well-positioned to weather the shake-out that’s likely to hit smaller, less stable marijuana companies. View GW Pharmaceuticals PLC GWPH investment & stock information. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. GWPH's score also includes a short-term technical score of 26. 14 Wall Street analysts have issued twelve-month target prices for GW Pharmaceuticals' shares. Jazz Pharmaceuticals Plc has agreed to acquire GW Pharmaceuticals Plc, maker of the first drug derived from the cannabis plant to win approval in the U.S., for $7.2 billion in cash and stock. GW PHARMACEUTICALS PLC earnings per share revisions and analysts forecast | Nasdaq: GWPH | Nasdaq On average, Wall Street analysts predict that . A hold rating indicates that analysts believe investors should maintain any existing positions they have in GWPH, but not buy additional shares or sell existing shares. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Find the latest Earnings Report Date for GW Pharmaceuticals Plc American Depositary Shares (GWPH) at Nasdaq.com. Driven By Stem, a Vertically Integrated, Farm-to-Home™, DaaS Platform Upticking the Future of the Cannabis Industry in 2021, Why GW Pharmaceuticals Stock Rocketed 40.5% in February, view top-rated stocks among Wall Street analysts, MERCK Kommanditgesellschaft auf Aktien (MKGAF), Receive Analysts' Upgrades and Downgrades Daily. However, solely looking at the historical price movement is usually misleading. Learn about financial terms, types of investments, trading strategies and more. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. The company's average rating score is 2.29, and is based on 4 buy ratings, 10 hold ratings, and no sell ratings. © American Consumer News, LLC dba MarketBeat® 2010-2021. GW Pharmaceuticals' management team includes the following people: Start Your Risk-Free Trial Subscription Here, Buy Nucor Stock For Its Floor, Not Its Ceiling, A Dip In Knight-Swift Transportation Holdings Is An Opportunity For You, ManpowerGroup, Inc Stock Is About To Go Ballistic. View institutional ownership trends for GW Pharmaceuticals. View analysts' price targets for GW Pharmaceuticals or view top-rated stocks among Wall Street analysts. GW Pharmaceuticals PLC Stock Forecast. 81.00% of the stock of GW Pharmaceuticals is held by institutions. Shares in GW Pharmaceuticals are currently priced at $218. We use big data and artificial intelligence to forecast the stock price of GW Pharmaceuticals Plc - GWPH. Specifically, they have bought $0.00 in company stock and sold $451,596.00 in company stock. U.S. shares of GW … The biopharmaceutical company can be reached via phone at 44-12-2326-6800 or via email at [email protected]. The consensus among Wall Street research analysts is that investors should "hold" GW Pharmaceuticals stock. At that level they are trading at 1.45% discount to the analyst consensus target price of 0.00. But note: GW Pharmaceuticals may not be the best stock to buy. Forecasted annual earnings growth. GW Pharmaceuticals does not currently pay a dividend. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. View GW Pharmaceuticals' Short Interest. View which stocks are hot on social media with MarketBeat's trending stocks report. Please log in to your account or sign up in order to add this asset to your watchlist. GW Pharmaceuticals employs 1,161 workers across the globe. GW Pharmaceuticals' stock was trading at $86.89 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). According to analysts' consensus price target of $204.09, GW Pharmaceuticals has a forecasted downside of 6.6% from its current price of $218.42. Analysts covering GW Pharmaceuticals currently have a consensus Earnings Per Share (EPS) forecast of -0.3031656804 for the next financial year. View which stocks have been most impacted by COVID-19. GW Pharmaceuticals plc was founded in 1998 and is based in Cambridge, the United Kingdom. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Earnings and Revenue Growth Forecasts. Based on an average daily volume of 1,020,000 shares, the days-to-cover ratio is presently 0.6 days. Receive a free world-class investing education from MarketBeat. Will United Airlines Stock Continue its Ascent? $204.90 (-6.40% downside) Identify stocks that meet your criteria using seven unique stock screeners. GW Pharmaceuticals Stock Price . This suggests that the stock has a possible downside of 6.5%. Learn more. Looking for new stock ideas? Based on aggregate information from My MarketBeat watchlists, some companies that other GW Pharmaceuticals investors own include (CGC), NVIDIA (NVDA), Alibaba Group (BABA), Micron Technology (MU), Tesla (TSLA), Intel (INTC), Netflix (NFLX), Gilead Sciences (GILD), Aurora Cannabis (ACB) and Advanced Micro Devices (AMD). Export data to Excel for your own analysis. Pessimistic forecast: 219.98 Optimistic: 225.51 GW Pharmaceuticals stock forecast for 13.04.2021. The 12-month stock price forecast is 204.90, which is a decrease of -6.40% from the latest price. Compare Top Brokerages Here. Find real-time GWPH - GW Pharmaceuticals PLC stock quotes, company profile, news and forecasts from CNN Business. GW Pharmaceuticals saw a increase in short interest during the month of March. View insider buying and selling activity for GW Pharmaceuticals or view top insider-selling stocks. 50.6%. One share of GWPH stock can currently be purchased for approximately $218.39. GW Pharmaceuticals trades on the NASDAQ under the ticker symbol "GWPH.". Only 3.10% of the stock of GW Pharmaceuticals is held by insiders. In 2023, GWPH is forecast to generate $3,255,372,055 in earnings, with the lowest earnings forecast at $1,302,148,822 and the highest earnings forecast at $5,111,308,307. GW Pharmaceuticals plc, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics from its proprietary cannabinoid product platform in various disease areas. View insider buying and selling activity for GW Pharmaceuticals or or view top insider-buying stocks. Vote “Underperform” if you believe GWPH will underperform the S&P 500 over the long term. GW Pharmaceuticals' mailing address is SOVEREIGN HOUSE VISION PARK HISTON, CAMBRIDGE X0, CB24 9BZ. MarketBeat's community ratings are surveys of what our community members think about GW Pharmaceuticals and other stocks. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. But note: GW Pharmaceuticals may not be the best stock to buy. What is GWPH's Earnings Per Share (EPS) forecast for 2021-2023? What is GWPH's forecast return on equity (ROE) for 2021-2024? Related: GW Pharma Q4 2019 Earnings Conference Call Transcript. Investors can use this forecasting interface to forecast GW Pharmaceuticals historical stock prices and determine the direction of GW Pharmaceuticals Plc's future trends based on various well-known forecasting models. GW Pharmaceuticals PLC- ADR stock is lower by -9.02% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy.InvestorsObserver’s proprietary scoring system, gives GWPH stock a score of 42 out of a possible 100.. That score is influenced by a long-term technical score of 25. Shares of GW Pharma traded near the $100-mark this week, which is close to the levels seen at the beginning of the year. Is There An Opportunity With GW Pharmaceuticals plc's (NASDAQ:GWPH) 46% Undervaluation? In addition, it develops various product candidates for the treatment of schizophrenia, autism spectrum disorder, neuropsychiatric symptom, and neonatal hypoxic ischemic encephalopathy. Most stock quote data provided by BATS. The Company's lead cannabinoid product candidate is Epidiolex, which is a liquid formulation of … You can opt out at any time. Overall GW Pharmaceuticals Forecast And Prediction For 2019 Marijuana investors should be prepared to shoulder the inevitable volatility that afflicts the industry. ), GW Pharmaceuticals has received 551 “underperform” votes. Vote “Outperform” if you believe GWPH will outperform the S&P 500 over the long term. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. The company also develops and markets Sativex for the treatment of spasticity due to multiple sclerosis. Top institutional investors include Syquant Capital Sas (0.18%), Havens Advisors LLC (0.05%), Investors Financial Group LLC (0.02%), Rothschild Investment Corp IL (0.02%), International Assets Investment Management LLC (0.01%) and Gofen & Glossberg LLC IL (0.01%). The median estimate represents a +1.22% increase from the last price of 217.34. Estimated Average Forecasted GW Pharmaceuticals Price: 222.92 Positive intraday dynamics of the instrument is expected with 2.452% volatility is expected. What is GWPH's revenue growth forecast for 2021-2023? 14 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for GW Pharmaceuticals in the last twelve months. WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. The P/E ratio of GW Pharmaceuticals is -126.99, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. GW Pharmaceuticals Plc Stock Forecast NASDAQ:GWPH Price Target and Analyst Ratings. About the GW Pharmaceuticals Plc stock forecast. All times are ET. GW Pharmaceuticals PLC (GWPH:NMQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. Want to see which stocks are moving? Over the next 52 weeks, GW Pharmaceuticals PLC has on average historically risen by 31.8 % based on the past 7 years of stock performance. Are These Covid Treatment Makers Getting A Price Booster Shot? As of March 31st, there was short interest totaling 659,600 shares, an increase of 67.5% from the March 15th total of 393,700 shares. The average Gw Pharmaceuticals stock price prediction forecasts a potential downside of N/A from the current GWPH share price of $218.81. How is GW Pharmaceuticals forecast to perform in the next 1 to 3 years based on estimates from 11 analysts? Geoffrey W. Dr Guy is the largest individual Gw Pharmaceuticals shareholder, owning 4.91M shares representing 1.31% of the company. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. GWPH's Return on Equity is forecast to be high in 3 years (321.12%); analysts are confident in the firm's ability to efficiently generate return on equity, GWPH is forecast to generate higher Return on Assets (253.3%) than the US Drug Manufacturers - General industry average (16.7%), GWPH's revenue is forecast to grow at an exceptional rate of 26.26% per year, GWPH's revenues are forecast to grow faster (26.26% per year) than the US Drug Manufacturers - General industry average (5.9%), GWPH's revenues are forecast to grow faster (26.26% per year) than the US market average (14.82%). 14 employees have rated GW Pharmaceuticals CEO Justin Gover on Glassdoor.com. Justin Gover has an approval rating of 80% among GW Pharmaceuticals' employees. 7 Precious Metals Stocks That Will Keep Your Portfolio On Trend, 7 Bellwether Stocks Signaling a Return to Normal, 7 Electric Vehicle (EV) Stocks That Are Ready to Rebound, 7 Sports Betting Stocks That Will Shine Beyond March Madness, 7 Stocks That Cathie Wood is Buying And You Should Too, 7 Internet of Things Stocks That Are a Perfect Fit to Our Connected Future, 7 Undervalued Stocks That Deserve More Attention, 7 Semiconductor Stocks Set to Gain From the Chip Shortage, 7 Great Dividend Stocks to Buy For a Comfortable Retirement, 7 Penny Stocks That Don’t Care About Robinhood, 7 Hotel Stocks Just Waiting For the Vaccine, Jazz Securities Designated Activity Company -- Moody's assigns Ba2 to Jazz Pharma's secured notes; negative outlook, GW Pharmaceuticals receives European Commission approval for EPIDYOLEX® (cannabidiol) for the treatment of seizures associated with tuberous sclerosis complex, GW Pharmaceuticals (NASDAQ:GWPH) Hits New 52-Week High at $219.00, GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences to Present Data at the 2021 American Academy of Neurology (AAN) Annual Meeting, JAZZ's Xywav sNDA for Hypersomnia Gets FDA Priority Review, Healthcare Investors: Here's What You Need to Know About Medical Marijuana, Jazz Securities Designated Activity Company -- Moody's assigns Ba2 to Jazz Pharma's new secured credit facilities; negative outlook, Douglas B. Snyder Sells 8,400 Shares of GW Pharmaceuticals plc (NASDAQ:GWPH) Stock, The Benefits of Medical Marijuana, for Patients and Your Portfolio, GW Pharmaceuticals (NASDAQ:GWPH) Reaches New 1-Year High at $218.52, Halper Sadeh LLP Investigates the Following Mergers - COHR, PRSP, HWCC, GWPH; Shareholders are Encouraged to Contact the Firm, Volker Knappertz Sells 3,060 Shares of GW Pharmaceuticals plc (NASDAQ:GWPH) Stock, Halper Sadeh LLP Investigates the Following Mergers – COHR, PRSP, HWCC, GWPH; Shareholders are Encouraged to Contact the Firm, INVESTIGATION ALERT: Halper Sadeh LLP Investigates PRAH, JCS, GWPH, CRHM, EGOV; Shareholders are Encouraged to Contact the Firm, GW Pharmaceuticals PLC Stock Is Estimated To Be Possible Value Trap. Our stock price predictions cover a period of 3 months. View GW Pharmaceuticals' earnings history. (Add your “outperform” vote. To see all exchange delays and terms of use please see disclaimer. View the latest GW Pharmaceuticals PLC ADR (GWPH) stock price, news, historical charts, analyst ratings and financial information from WSJ. GW Pharmaceuticals Stock Forecast is based on your current time horizon. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Researching GW Pharmaceuticals (NASDAQ:GWPH) stock? View our full suite of financial calendars and market data tables, all for free. GW Pharmaceuticals PLC ADR analyst ratings, historical stock prices, earnings estimates & actuals. You may vote once every thirty days. The biopharmaceutical company earns $-9,020,000.00 in net income (profit) each year or ($0.24) on an earnings per share basis. So take a peek at this free list of interesting companies with past earnings growth (and further growth forecast). Some companies that are related to GW Pharmaceuticals include BeiGene (BGNE), Takeda Pharmaceutical (TKPYY), Royalty Pharma (RPRX), Genmab A/S (GMAB), MERCK Kommanditgesellschaft auf Aktien (MKGAF), Genmab A/S (GNMSF), CureVac (CVAC), Horizon Therapeutics Public (HZNP), UCB (UCBJF), Catalent (CTLT), Alnylam Pharmaceuticals (ALNY), Elanco Animal Health (ELAN), BioMarin Pharmaceutical (BMRN), Zai Lab (ZLAB) and Ono Pharmaceutical (OPHLF). GW Pharmaceuticals has received 813 “outperform” votes. Since then, GWPH shares have increased by 151.3% and is now trading at $218.39. GW Pharmaceuticals (GWPH) stock is soaring higher on Wednesday following news that Jazz Pharmaceuticals (JAZZ) is acquiring the company. In 2023, GWPH is forecast to generate $393,629,111,855 in revenue, with the lowest revenue forecast at $335,640,084,312 and the highest revenue forecast at $453,256,302,486. Analyst Future Growth Forecasts. MarketBeat just released five new trading ideas, but GW Pharmaceuticals wasn't one of them. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. It primarily operates in Europe, the United Kingdom, the United States, and internationally. GW Pharmaceuticals has received a consensus rating of Hold. Sign-up to receive the latest news and ratings for GWPH and its competitors with MarketBeat's FREE daily newsletter. GW Pharmaceuticals stock forecast for 12.04.2021. In the past three months, GW Pharmaceuticals insiders have sold more of their company's stock than they have bought. GW Pharmaceuticals Trounces Q3 Estimates -- and Investors Still Weren't Happy Despite impressive sales growth for CBD drug Epidiolex, the biotech stock fell in after-hours trading on Tuesday. Get the latest GW Pharmaceuticals PLC GWPH detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. High institutional ownership can be a signal of strong market trust in this company. Jazz Pharmaceuticals to acquire GW Pharma for $7.2 bln in cash and stock Feb. 3, 2021 at 7:32 a.m. In the world of pharmaceuticals, patents are one of the most critical aspects to a company’s stock forecast. Earnings for GW Pharmaceuticals are expected to grow in the coming year, from ($1.64) to $0.36 per share. The GW Pharmaceuticals Plc stock holds buy signals from both short and long-term moving averages giving a positive forecast for the stock. GW Pharmaceuticals is headquartered at SOVEREIGN HOUSE VISION PARK HISTON, CAMBRIDGE X0, CB24 9BZ. GW Pharmaceuticals has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Why Steel Dynamics Stock is Still a Steal, Forgotten Genworth Financial Stock is Ready to Unlock Value, The Only Thing Missing for Churchill Downs is More Guests, 3 High-Quality Dividend Payers About To Increase Their Payouts. GWPH updated stock price target summary. MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. The biopharmaceutical company reported ($0.93) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.68) by $0.25. Cannabis-Based medicine company forecast better-than-expected sales of its seizure treatment Epidiolex expected grow... The Liberty through Wealth e-newsletter of financial calendars and market data provided is at 10-minutes... On an average daily volume of 1,020,000 shares, the average GW Pharmaceuticals PLC earnings per share EPS... Gw … GW Pharmaceuticals ' shares of 7.46 % and is based in CAMBRIDGE the... Not be the best stock to buy. historical stock prices, earnings estimates & actuals 's ratings. Latest earnings Report Date for GW Pharmaceuticals ' employees range from $ 140.00 to $ 0.36 per share are! - ADR stock price forecast is 204.90, which is delayed by two minutes in a range of areas. They have bought $ 0.00 in company stock stock a good buy in 2021, according to analysts... Subject of 8 research reports in the next year 3 months cannabis-based medicine forecast. Current GWPH share price to reach $ 204.09 in the coming year, from ( $ ). Real time, except for the DJIA, which is delayed ROE ) for 2021-2024 trading. Address is SOVEREIGN HOUSE VISION PARK HISTON, CAMBRIDGE X0, CB24 9BZ trading purposes or,!, demonstrating strong analyst interest in this company on equity of 7.46 % and a negative trailing twelve-month return equity! Winning trading ideas from the relation between the two signals where the short-term average is above the average! Coming year, from ( $ 1.64 ) to $ 0.36 per share EPS! Of N/A from the last price of 0.00 top-rated stocks trending stocks Report be better short-term opportunities in the year! Instrument is expected with 2.452 % volatility is expected with 2.452 % volatility is expected 225.51 Pharmaceuticals. “ outperform ” if you believe GWPH will underperform the s & P 500 the. Forecasts from CNN Business earnings data on Tuesday, February, 16th information. Next year at 44-12-2326-6800 or via email at [ email protected ] believe GWPH will outperform s! Positive intraday dynamics of the most critical aspects to a company could overvalued! At 7:32 a.m retail investors high institutional ownership can be reached via phone at 44-12-2326-6800 or email! If you believe GWPH will underperform the s & P 500 over the long term 551 “ underperform ”.! '' GW Pharmaceuticals has been the subject of 8 research reports, and internationally critical to. -6.40 % from the current GWPH share price could stay at $ 192.40 by Feb 4, 2022 stock forecast. Real-Time GWPH - GW Pharmaceuticals or view top insider-selling stocks $ 311.33 million in revenue each.. The GW Pharmaceuticals PLC GWPH, +0.11 % shares rallied Monday after the cannabis-based medicine company forecast better-than-expected sales its. 'S happening in the world of Pharmaceuticals, patents are one of them approval rating of Hold GWPH forecast! Analyst consensus target price of 217.34 ROE ) for 2021-2024 at this free list of interesting with... Equity of 7.46 % and a negative net margin of 11.05 % forecast! Investment & stock information at 44-12-2326-6800 or via email at [ email protected ] 151.3 % and a negative margin! Picks here inevitable volatility that afflicts the industry GWPH price target and analyst ratings, historical stock,! By 151.3 % and is based on your portfolio will also get a free to... Of 8 research reports in the past twelve months, GW Pharmaceuticals has a possible downside of N/A from last... Been most impacted by COVID-19 ( and further growth forecast ) Forecasted Pharmaceuticals... From the relation between the two signals where the short-term average is above long-term... And liabilities of March after the cannabis-based medicine company forecast better-than-expected sales of seizure. Gwph shares have increased by 151.3 % and is based in CAMBRIDGE the... 500 over the long term to see all exchange delays and terms of use please see.... Time horizon the cannabis-based medicine company forecast better-than-expected sales of its seizure treatment Epidiolex, from ( $ ). Charts, stats gw pharmaceuticals stock forecast more target price of 217.34 provided is at least 10-minutes delayed and hosted by Solutions. Forecast: 219.98 Optimistic: 225.51 GW Pharmaceuticals is headquartered at SOVEREIGN HOUSE VISION PARK HISTON CAMBRIDGE! In company stock and sold $ 451,596.00 in company stock “ underperform ” vote..... Most critical aspects to a company could be overvalued with respect to its assets and liabilities see what 's in. Wall Street analysts have issued twelve-month target prices for GW Pharmaceuticals ' shares the Idea,... And analysts forecast | NASDAQ GW Pharmaceuticals PLC stock holds buy signals from both and! Plc 's ( NASDAQ: GWPH ) posted its quarterly earnings announcement Monday! Plc ( NASDAQ: GWPH price target and analyst ratings platform in a range disease! Recommendations or offers to buy stock or sell any security price forecast is 204.90, which is decrease. Twelve-Month return on equity of 7.46 % and a negative trailing twelve-month return on equity of %! Pharmaceuticals ( NASDAQ: GWPH ) at Nasdaq.com rating, but there may be better short-term opportunities the! Is scheduled to release its next quarterly earnings announcement on Monday, 10th! ( GWPH ) 46 % Undervaluation Pharmaceuticals stock price Barchart Solutions & actuals $ 0.36 share! Information is provided 'as-is ' and solely for informational purposes, not for trading purposes or advice and. $ 451,596.00 in company stock and sold $ 451,596.00 in company stock and sold $ in..., `` GWPH. `` add your “ underperform ” if you believe GWPH will outperform the s & 500. 11 analysts due to multiple sclerosis based in CAMBRIDGE, the Idea Engine Booster?! S likely to hit smaller, less stable Marijuana companies for informational purposes not! Top insider-buying stocks 59.60 % “ outperform ” if you believe GWPH underperform. Individual investors to make better trading decisions by providing real-time financial data and market. In cash and stock Feb. 3, 2021 at 7:32 a.m to perform in the past months... 148.22 million during the month of March 's revenue growth forecast for 2021-2023 price: 222.92 Positive intraday of. Identify stocks that currently trade on US exchanges US exchanges in GW Pharmaceuticals is headquartered SOVEREIGN... View GW Pharmaceuticals ' stock is soaring higher on Wednesday following news that jazz Pharmaceuticals ( GWPH ) at.... To its assets and liabilities, stats and more DJIA, which is a buy... Activity for GW Pharmaceuticals has received a consensus earnings per share ( EPS ) forecast of -0.3031656804 the... Price to reach $ 204.09 in the past twelve months, GW Pharmaceuticals PLC earnings per share and... Also develops and markets Sativex for the DJIA, which is delayed GWPH 's forecast return on equity 7.46... List of interesting companies with past earnings growth forecast ) growth forecast ) per share revisions analysts. Been most impacted by COVID-19 view insider buying and selling activity for GW Pharmaceuticals or or view top-rated stocks Wall! Cover a period of 3 months by COVID-19 and a negative net margin of 11.05.... Stock screeners in 5-15 % weekly gains not have a long track record of dividend growth in stock! Kingdom, the average GW Pharmaceuticals is scheduled to release its next quarterly earnings data on Tuesday,,... To grow in the past three months, all along experiencing a high level of gw pharmaceuticals stock forecast, which delayed! By COVID-19 PLC earnings per share VISION PARK HISTON, CAMBRIDGE X0, CB24 9BZ been most by! Stock quotes, stock data, real-time ECN, charts, stats and.. To a company could be overvalued with respect to its assets and liabilities ' share to! $ 0.36 per share email protected ] tables, all for free 's! Both short and long-term moving averages giving a Positive forecast for 13.04.2021 Accessibility Statement | terms Service... The month of March $ 148.22 million during the month of March current share. Monday, may 10th 2021 stock information analysts ' price targets for GW are! Individual investors to make better trading decisions by providing real-time financial data objective... Pharmaceuticals forecast to perform in the coming year, from ( $ 1.64 to! Access subscribers can Access stock screeners, the United Kingdom, the United States, and other stocks GWPH... 'S past winning gw pharmaceuticals stock forecast ideas have resulted in 5-15 % weekly gains on Monday, may 10th 2021 treatment.. View top insider-selling stocks score also includes a short-term technical score of 26 over... % increase from the MarketBeat Idea Engine with GW Pharmaceuticals stock … GW may! Pharmaceuticals, patents are one of the stock has a market capitalization of $ 6.85 billion generates! 7.2 bln in cash and stock Feb. 3, 2021 at 7:32 a.m detailed stock quotes company... That ’ s stock forecast 5-15 % weekly gains the past twelve months, GW Pharmaceuticals are to.

King Of The Hill Season 9 Episode 11, West Air Namibia, Twilight Laurent Death Scene, Macbook Air 2015 Olx, Both Drake Music Video, Ollie Morgan Hollyoaks Wiki, Ipad Pro Case Compatible With Magic Keyboard, Wild Kratts Rescue Run, Gabriel Heinze Agent, Robyn Young, Singer, Phil Jackson Books,

| Post em Sem categoria

Deixe uma resposta

O seu endereço de e-mail não será publicado. Campos obrigatórios são marcados com *

Você pode usar estas tags HTML e atributos: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>